To promote affordable access to evidence-based opioid treatments under the Medicare program and require coverage of medication assisted treatment for opioid use disorders, opioid overdose reversal medications, and recovery support services by health plans without cost-sharing requirements.
About This Bill
Committee
Latest Action · March 15, 2023
Read twice and referred to the Committee on Finance.